Iloprost clinical trials
Also written Ventavis, Ilomedin and ZK 36374.
How each study uses Iloprost is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Iloprost studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 2004 · VENTAVIS · NDA 021779 (FDA, Drugs@FDA)
- European Union
- 15 Sept 2003 · Ventavis · EMEA/H/C/000474 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
61 studies that test it; most in 2006 (9); 1 more planned to start later
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 9 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 48
Actelion (8) · Pär Johansson (4) · Yonsei University (3) · Bayer (3) · Charite University, Berlin, Germany (3) · University of Oklahoma (2) · National Cancer Institute (NCI) (2) · Shanghai Jiao Tong University School of Medicine (2)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Iloprost.
- Sep 2027Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory FailurePhase 2 · Pär Johansson
Studies
Open first, then newest update. How each study uses Iloprost is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 62
- Local Iloprost Therapy to Promote Bone Healing in High Risk FracturesNot yet recruitingPhase 2Charite University, Berlin, GermanyNCT07924722Written as IlomedinHow we know
- Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial HypertensionRecruitingPhase 4University of Sao Paulo General HospitalNCT07713914Written as Prostacyclin Pathway AgentHow we know
- Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell DiseaseNot yet recruitingPhase 3University Hospital, RouenNCT07498309Written as IloprostHow we know
- Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory FailureRecruitingPhase 2Pär JohanssonNCT06319274Written as IloprostHow we know
- Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedPhase 3ActelionNCT00709956Written as iloprost (5 µg)How we know
- The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial HypertensionTerminatedPhase 3ActelionNCT00302211Written as Inhaled Iloprost (5 μg)How we know
- Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric OxideTerminatedPhase 4Duke UniversityNCT02170519Written as Inhaled IloprostHow we know
- ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)CompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT03788837Written as ILOPROSTHow we know
- Oral Iloprost for the Prevention of Lung Cancer In Former SmokersWithdrawnPhase 2National Cancer Institute (NCI)NCT05411107Written as IloprostHow we know
- Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ FailureCompletedPhase 2Pär JohanssonNCT03903939Written as IloprostHow we know
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ FailureCompletedPhase 2/3Jakob Stensballe, MD, PhDNCT04123444Written as IloprostHow we know
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory FailureCompletedPhase 2Pär JohanssonNCT04420741Written as IloprostHow we know
- Outpatient Vasodilator Assessment Using Iloprost in Pulmonary HypertensionTerminatedPhase 4Duke UniversityNCT03044314Written as Iloprost and nitric oxide administrationHow we know
- Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNot applicableUniversity of OklahomaNCT00561223Written as iloprost InhalationHow we know
- Iloprost in Preventing Lung Cancer in Former SmokersCompletedPhase 1National Cancer Institute (NCI)NCT02237183Written as IloprostHow we know
- A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral FractureStatus unknownPhase 1/2Charite University, Berlin, GermanyNCT04543682Written as 0.125 ng/kg/min IloprostHow we know
- Inhaled Iloprost for Suspected COVID-19 Respiratory FailureCompletedPhase 2Hamad Medical CorporationNCT04445246Written as Inhaled ILOPROSTHow we know
- Iloprost in Acute Respiratory Distress SyndromeCompletedPhase 3University Hospital TuebingenNCT03111212Written as IloprostHow we know
- Endothelial Dysfunction in Resuscitated Cardiac ArrestCompletedPhase 2Pär JohanssonNCT02685618Written as IloprostHow we know
- Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft SurgeryStatus unknownNot applicableYonsei UniversityNCT04598191Written as IloprostHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
- Local Iloprost Therapy to Promote Bone Healing in High Risk FracturesNov 9, 2026NCT07924722
Codes
What other systems call Iloprost · ClinicalTrials.gg INT008525
- MeSH (NLM) D016285IloprostConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JED5K35YGLILOPROSTConfirmed FDA, NLM, Wikidata
- RxNorm 40138Confirmed FDA, Wikidata
- Wikidata Q20817139iloprostConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48397IloprostOne source FDA
- DrugBank DB01088One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016285 | Iloprost | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JED5K35YGL | ILOPROST | Confirmed FDA, NLM, Wikidata |
| RxNorm | 40138 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20817139 | iloprost | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48397 | Iloprost | One source FDA |
| DrugBank | DB01088 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.